Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
6
NMPA:6
Drug Approvals
Ambroxol Hydrochloride Oral Solution
- Product Name
- 盐酸氨溴索口服溶液
- Approval Number
- 国药准字H20254360
- Approval Date
- May 27, 2025
NMPA
Ambroxol Hydrochloride Oral Solution
- Product Name
- 盐酸氨溴索口服溶液
- Approval Number
- 国药准字H20249794
- Approval Date
- Dec 25, 2024
NMPA
Sodium Valproate Oral Solution
- Product Name
- 丙戊酸钠口服溶液
- Approval Number
- 国药准字H20249518
- Approval Date
- Dec 1, 2024
NMPA
Urapidil Hydrochloride Injection
- Product Name
- 盐酸乌拉地尔注射液
- Approval Number
- 国药准字H20249145
- Approval Date
- Oct 22, 2024
NMPA
Urapidil Hydrochloride Injection
- Product Name
- 盐酸乌拉地尔注射液
- Approval Number
- 国药准字H20249146
- Approval Date
- Oct 22, 2024
NMPA
Aminocaproic Acid Injection
- Product Name
- 氨基己酸注射液
- Approval Number
- 国药准字H20243608
- Approval Date
- Apr 24, 2024
NMPA
Clinical Trials
No trials found
News
No news found